Inovio to participate in the citizens jmp novel therapeutics forum at penn medicine

Plymouth meeting, pa. , march 26, 2024 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that dr. jacqueline shea, president and ceo will participate in the novel therapeutics forum hosted by citizens jmp at penn medicine at 10:00 am et on april 2, 2024.
INO Ratings Summary
INO Quant Ranking